Signaling pathways in Ras-mediated tumorigenicity and metastasis.
about
MAP kinase phosphatasesActivation of CD4 T cells by Raf-independent effectors of Rasp19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathwaysKirsten Ras* oncogene: Significance of its discovery in human cancer researchMitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancerInteraction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1Identification and characterization of rain, a novel Ras-interacting protein with a unique subcellular localizationCrk activation of JNK via C3G and R-RasR-Ras regulates beta1-integrin trafficking via effects on membrane ruffling and endocytosis.The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression.Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathwayCooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesisGenetic events and the role of TGF beta in epithelial tumour progression.Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinaseInduction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathwaysInteractions of DNA helicases with damaged DNA: possible biological consequences.CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescenceClarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppressionPhosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasivenessSuppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysRas induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastasesOncogenic Ras in tumour progression and metastasis.Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathway.Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathwayERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.The mutationally activated Met receptor mediates motility and metastasis.Regulation of MAPKs by growth factors and receptor tyrosine kinasesExpression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.The chemopreventive agent myoinositol inhibits Akt and extracellular signal-regulated kinase in bronchial lesions from heavy smokers.Essential genes in thyroid cancers: focus on fascin.ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivoNuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathwayExpression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations.Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infectionTargeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases
P2860
Q21999790-58B23297-7BF0-42D1-A957-E0B6ED9ABD66Q24675067-94C7CE52-0D2C-4257-A2A4-62AEAE5F940BQ24799059-F3306E5D-9E0D-4869-95A6-D04FA0BE3DD3Q26751212-6FF20B42-D5F8-41FE-81E3-DB466D8F7D55Q26778022-ACA8971B-576B-43E0-BB90-B9B57752A8BAQ28208695-EC445A3C-1C7C-4887-9459-0A1D1EE818F2Q28251364-191B462B-D57B-43FD-B92E-AB222AE9E8BEQ28609331-204C2B58-2A4E-494E-B8F7-99F1ABA21C02Q30493448-32492B3E-A213-40CE-B001-C8BC83D76D28Q30818809-20C0E00E-BE36-4CC1-9257-1B4C10952D42Q33517958-4DADBA8D-DFB3-4E25-983C-F98FEDCE1583Q33601436-6F775911-BB47-4918-9CF9-C92551D242F4Q33643339-4E8C8703-E3C1-47B1-9AB8-BDA7ED66C052Q33823577-EB0B8A58-DD14-4DA3-AE34-629B9BFA701AQ33943764-11E85B09-5B2F-46D1-9F9C-A485F065B783Q33968056-DE17A1BC-E53A-4E26-83C0-756BCB5B38F4Q33969356-3E3CB4F5-D019-411F-B647-74A98F1C02FCQ34011942-62BB2969-A735-4555-BFE6-41C36D61D26BQ34134934-E450BF36-64FB-4461-AEA0-586CC49334C9Q34519801-893065E2-6E23-4BB1-A78A-965E3CE24514Q34648711-54DCC7E5-2C56-47C3-90AB-0304333883DDQ35022183-F4CD212F-3627-42A4-A916-9C689912D4FAQ35054868-7F03FB39-E9DC-4CB2-B566-D80B236AEF0AQ35226147-DD6A789D-B24C-4782-8678-E02155C83FDEQ36071767-E526A93A-9F36-411B-9E50-6D70F45A705CQ36103287-A5B6DDA5-315D-4EC6-9513-48238DF613DEQ36360393-1787FC2D-95D8-4000-9617-71C33F7EFE5DQ36623415-8939E66D-505B-4BA9-BDC8-A348E798524BQ36641404-27E36369-4878-4F8C-B42D-741A4F1402BCQ36694670-C49121F2-E64C-4CA6-A74A-9E00AE27450FQ36735738-B04B15B3-79B6-4B7A-929E-C8E8217CEEC9Q36738312-D9CBBF92-7C6C-41C5-A485-0BB066A49970Q36924443-93086AD2-BCFA-438F-BD57-F97935506906Q37023660-0E0E9056-C271-4B88-849D-AA8066D56556Q37071818-EA2833C1-2301-48C4-BF43-B50502071573Q37142879-93E66D14-0C03-4773-A184-E18D828E7380Q37177311-9A04082A-AF9F-4C23-9BA3-A26A93C5AF2FQ37215137-9E15D20F-7EF1-4F7A-A9C9-FBC8B085C064Q37285576-43FB845F-43FD-4DDD-AF8E-4A6C23653A22Q37421620-8F8D9132-0725-4195-9FB6-CE1D3B219BDB
P2860
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
@ast
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
@en
type
label
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
@ast
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
@en
prefLabel
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
@ast
Signaling pathways in Ras-mediated tumorigenicity and metastasis.
@en
P2093
P2860
P356
P1476
Signaling pathways in Ras-mediated tumorigenicity and metastasis
@en
P2093
G F Vande Woude
L Van Aelst
P2860
P304
P356
10.1073/PNAS.95.15.8773
P407
P577
1998-07-01T00:00:00Z